Antiretroviral Clinical Trials – Breaking News
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir- Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study.
Castagna A et al, The Journal of Infectious Diseases 2014;210:354–62
Posted on November 18th, 2014 - Pr Pedro Cahn
- Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Refl ate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Grinsztejn B et al, Lancet Infect Dis 2014; 14: 459–67
Posted on November 18th, 2014 - Dr Anton Pozniak
- Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide. An Analysis of Trial Data.
Mollan KR et al, Ann Intern Med. 2014;161:1-10
Posted on November 18th, 2014 - Pr François Raffi
- Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.
Whitney JB et al, Nature (2014) doi:10.1038/nature13594
18 Novembre 2014 - Pr François Raffi
Back to Home page
|